Report: Drug maker was focused on profits, not patients
Tuesday, December 1, 2015 - 12:40
in Mathematics & Economics
WASHINGTON (AP) -- The makers of a breakthrough drug for hepatitis C put profits before patients in pricing the $1,000 pill that cures the liver-wasting disease, Senate investigators said Tuesday....